- Home
- CIVB vs TKNO Comparison
CIVB vs TKNO Comparison
Compare CIVB & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVB
- TKNO
- Stock Information
- Founded
- CIVB 1884
- TKNO 1996
- Country
- CIVB United States
- TKNO United States
- Employees
- CIVB N/A
- TKNO N/A
- Industry
- CIVB Major Banks
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- CIVB Finance
- TKNO Health Care
- Exchange
- CIVB Nasdaq
- TKNO Nasdaq
- Market Cap
- CIVB 422.4M
- TKNO 340.9M
- IPO Year
- CIVB N/A
- TKNO 2021
- Fundamental
- Price
- CIVB $21.89
- TKNO $4.49
- Analyst Decision
- CIVB Buy
- TKNO
- Analyst Count
- CIVB 5
- TKNO 0
- Target Price
- CIVB $25.40
- TKNO N/A
- AVG Volume (30 Days)
- CIVB 78.6K
- TKNO 190.3K
- Earning Date
- CIVB 10-23-2025
- TKNO 11-06-2025
- Dividend Yield
- CIVB 3.10%
- TKNO N/A
- EPS Growth
- CIVB 33.31
- TKNO N/A
- EPS
- CIVB 2.66
- TKNO N/A
- Revenue
- CIVB $163,095,000.00
- TKNO $39,801,000.00
- Revenue This Year
- CIVB $18.06
- TKNO $9.52
- Revenue Next Year
- CIVB $10.83
- TKNO $15.20
- P/E Ratio
- CIVB $8.23
- TKNO N/A
- Revenue Growth
- CIVB 11.28
- TKNO 9.50
- 52 Week Low
- CIVB $17.47
- TKNO $3.94
- 52 Week High
- CIVB $25.59
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- CIVB 58.77
- TKNO 38.48
- Support Level
- CIVB $21.19
- TKNO $4.26
- Resistance Level
- CIVB $22.19
- TKNO $5.00
- Average True Range (ATR)
- CIVB 0.41
- TKNO 0.38
- MACD
- CIVB 0.00
- TKNO -0.09
- Stochastic Oscillator
- CIVB 73.00
- TKNO 13.83
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.